カルシトニン遺伝子関連ペプチドを標的とする:片頭痛治療の新時代
Andrew Charles1, Patricia Pozo-Rosich2
1UCLA Goldberg Migraine Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Lancet (London, England)
|November 1, 2019
まとめ
カルシトニン遺伝子関連ペプチド (CGRP) を標的とした新しい治療法は,片頭痛の治療に有意な効果を示しています. モノクローナル抗体を含むCGRPを標的とする治療法は この神経疾患の管理に有望な進歩をもたらします
科学分野:
- 神経科学
- 薬理学について
背景:
- 偏頭痛は 非常によく発生し 障害となる神経疾患です
- 最近まで 偏頭痛の特異的な治療法は 限られていました
研究 の 目的:
- カルシトニン遺伝子関連ペプチド (CGRP) を標的とした新型片頭痛特有の治療法の開発と有効性を検討する.
主な方法:
- 片頭痛におけるCGRPの役割に関する基礎的および臨床的科学的調査のレビュー
- CGRP受容体アンタゴニストとモノクローナル抗体の臨床試験データの分析
主要な成果:
- 強い証拠は,CGRPが頭痛の病理生理学に関係している.
- CGRPを標的とした治療は,急性および予防的な治療において統計的に有意な有効性を示しています.
- モノクローナル抗体療法では,安全性と耐受性のプロファイルが好ましい.
結論:
- CGRPを標的とした治療戦略は 片頭痛の管理における 重要な進歩を表しています
- これらの新しい治療法は 片頭痛患者の臨床実務を変革する可能性を秘めています
関連する概念動画
Synthesis and Functions of Calcitonin
4.0K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
4.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
502
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
502
Calmodulin-dependent Signaling
5.9K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K


